Paper Review Records
全部论文审稿周期
21 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
4
天
Informing the debate: hypomethylating agents/venetoclax or intensive chemotherapy to treat acute myeloid leukemias
作者
Michael Daunov; Yogen Saunthararajah展开收起
作者单位
1. Department of Hematology and Oncology, University Hospitals; 2. School of Medicine, Case Western Reserve University; 3. Taussig Cancer Institute, Cleveland Clinic展开收起
61
天
2
天
143
天
The impact of radiotherapy on the therapeutic response of patients treated with CAR T-cell therapy for high-grade lymphoma: a systematic review
作者
Maïfa Belghoul; Andrea Kuhnl; Timothy Chevassut; Robin Sanderson; George Mikhaeel; Reuben Benjamin; Piers Patton; John Jones展开收起
作者单位
1. Department of Clinical Experimental Medicine, Brighton and Sussex Medical School; 2. University Hospitals Sussex NHS Trust; 3. King’s College Hospital展开收起
152
天
Linvoseltamab versus elranatamab for triple-class exposed relapsed or refractory multiple myeloma: an indirect treatment comparison
作者
Joshua Richter; Hans C. Lee; Sundar Jagannath; Jeffrey A. Zonder; James E. Hoffman; Zheng-Yi Zhou; Viviana Garcia-Horton; Mirko Fillbrunn; Hongjue Wang; Matthew Mattera; Timothy J. Inocencio; Yingxin Xu; James Harnett; Tito Roccia; Glenn S. Kroog; Karen Rodriguez Lorenc; Kate Knorr; Qiufei Ma; Naresh Bumma展开收起
作者单位
1. The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai; 2. Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center; 3. Karmanos Cancer Institute, Wayne State University School of Medicine; 4. University of Miami Health System; 5. Analysis Group, Inc.; 6. Regeneron Pharmaceuticals, Inc.; 7. The Ohio State University Comprehensive Cancer Center展开收起
89
天
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
